These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7886073)

  • 1. Age-dependent effects of NGF and scopolamine on suckling behavior of neonatal mice.
    Calamandrei G; Valanzano A
    Pharmacol Biochem Behav; 1994 Dec; 49(4):1043-8. PubMed ID: 7886073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NGF and cholinergic control of behavior: anticipation and enhancement of scopolamine effects in neonatal mice.
    Calamandrei G; Valanzano A; Alleva E
    Brain Res Dev Brain Res; 1991 Aug; 61(2):237-41. PubMed ID: 1661212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal exposure to anti-nerve growth factor antibodies affects exploratory behavior of developing mice in the hole board.
    Calamandrei G; Pennazza S; Ricceri L; Valanzano A
    Neurotoxicol Teratol; 1996; 18(2):141-6. PubMed ID: 8709925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic administration of anti-NGF antibodies to neonatal mice impairs 24-h retention of an inhibitory avoidance task while increasing ChAT immunoreactivity in the medial septum.
    Calamandrei G; Ricceri L; Valanzano A
    Behav Brain Res; 1996 Aug; 78(2):81-91. PubMed ID: 8864040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment of young mice with nerve growth factor enhances scopolamine-induced hyperactivity.
    Alleva E; Aloe L; Laviola G
    Brain Res; 1986 Aug; 393(2):278-81. PubMed ID: 3742245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of serotonergic and cholinergic antagonists on suckling behavior of neonatal, infant, and weanling rat pups.
    Ristine LA; Spear LP
    Behav Neural Biol; 1984 Jul; 41(2):99-126. PubMed ID: 6487222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraventricular injection of NGF, but not BDNF, induces rapid motor activation that is inhibited by nicotinic receptor antagonists.
    Kobayashi S; Ogren SO; Ebendal T; Olson L
    Exp Brain Res; 1997 Sep; 116(2):315-25. PubMed ID: 9348130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic treatment with scopolamine and physostigmine changes nerve growth factor (NGF) receptor density and NGF content in rat brain.
    Alberch J; Carman-Krzan M; Fabrazzo M; Wise BC
    Brain Res; 1991 Mar; 542(2):233-40. PubMed ID: 1851454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suckling behavior in neonatal rats: psychopharmacological investigations.
    Spear LP; Ristine LA
    J Comp Physiol Psychol; 1982 Apr; 96(2):244-55. PubMed ID: 6121827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholinergic control of nerve growth factor in adult rats: evidence from cortical cholinergic deafferentation and chronic drug treatment.
    Rossner S; Wörtwein G; Gu Z; Yu J; Schliebs R; Bigl V; Perez-Polo JR
    J Neurochem; 1997 Sep; 69(3):947-53. PubMed ID: 9282916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal cocaine alters behavioural responsiveness to scopolamine and cholinergic development in mice.
    Calamandrei G; Ricceri L; Valanzano A
    Pharmacol Biochem Behav; 1997 Apr; 56(4):557-63. PubMed ID: 9130277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment of passive avoidance learning following repeated administrations of antibodies against nerve growth factor in neonatal mice.
    Ricceri L; Alleva E; Calamandrei G
    Neuroreport; 1994 Jun; 5(11):1401-4. PubMed ID: 7919209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective role of nerve growth factor against excitatory amino acid injury during neostriatal cholinergic neurons postnatal development.
    Pérez-Navarro E; Alberch J
    Exp Neurol; 1995 Oct; 135(2):146-52. PubMed ID: 7589325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal scopolamine or antidepressant treatment: effect on development of hamster circadian rhythms.
    Klemfuss H; Gillin JC
    Pharmacol Biochem Behav; 1998 Feb; 59(2):369-73. PubMed ID: 9476983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of cholinergic mediation of behavior in 7-, 9-, and 12-day old rat pups.
    Smith GJ; Spear LP; Spear NE
    Pharmacol Biochem Behav; 1982 May; 16(5):805-9. PubMed ID: 7089037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal growth factors, neurotrophins and memory deficiency.
    Calamandrei G; Alleva E
    Behav Brain Res; 1995 Jan; 66(1-2):129-32. PubMed ID: 7755882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for an involvement of muscarinic cholinergic systems in the induction but not expression of behavioral sensitization to cocaine.
    Heidbreder CA; Shippenberg TS
    Synapse; 1996 Oct; 24(2):182-92. PubMed ID: 8890460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nerve growth factor attenuates cholinergic deficits following traumatic brain injury in rats.
    Dixon CE; Flinn P; Bao J; Venya R; Hayes RL
    Exp Neurol; 1997 Aug; 146(2):479-90. PubMed ID: 9270059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute administration of lithium carbonate interferes with suckling in neonatal rats.
    McLaughlin CR; Cramer CP
    Pharmacol Biochem Behav; 1989 Feb; 32(2):453-8. PubMed ID: 2498909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scopolamine prevents augmentation of stereotypy induced by chronic methamphetamine treatment.
    Ohmori T; Abekawa T; Koyama T
    Psychopharmacology (Berl); 1995 Sep; 121(2):158-63. PubMed ID: 8545520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.